MARATTO

article · Data in Brief

Insilico evaluation on potential Mt-Sp1/matriptase inhibitors data: DFT and molecular modelling approaches

Abstract

Nine heterocyclic compounds were investigated using density functional theory, molecular operating environment software, material studio, swissparam (Swiss drug design) software. In this work, the descriptors generated from the optimized compounds proved to be efficient and explain the level of reactivity of the investigated compound. The developed quantitative structure activity relationship (QSAR) model was predictive and reliable. Also, compound 9 proved to be capable of inhibiting Mt-Sp1/Matriptase (pdb id: 1eax) than other examined heterocyclic compounds. Target prediction analysis was carried out on the compound with highest binding affinity (Compound 9) and the results were reported.

Research topics

  • Computational Drug Discovery Methods
  • Synthesis and biological activity
  • Click Chemistry and Applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.dib.2024.110565

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.